Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 1,140 All time
- Disclosed funding
- $47.7B 980 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
Novee provides AI-powered penetration-testing software. | $51.5M | Series A | Cybersecurity | Israel | Investors | |
| E Builds talent pipelines for roles AI can't replace | $30M | Series A | Healthtech | India | Investors | |
| B BotsyncCompany profile Industrial automation company combining mobile robots and vendor-agnostic orchestration software for factories and warehouses. Industrial automation company combining mobile robots and vendor-agnostic orchestration software for factories and warehouses. | Undisclosed | Series A extensionSeries A | Robotics | Singapore | Investors | |
| CT Caldera TherapeuticsCompany profile Develops bispecific antibody CLD-423 for inflammatory bowel disease Develops bispecific antibody CLD-423 for inflammatory bowel disease | $37.5M | Series A1Series A | Biotech | United States | Investors | |
| d depthfirstCompany profile Develops AI-native security platform for software vulnerability detection and fix recommendations Develops AI-native security platform for software vulnerability detection and fix recommendations | $40M | Series A | Cybersecurity | United States | Investors | |
| PE Project ElevenCompany profile Builds tools for post-quantum security and migration for digital assets Builds tools for post-quantum security and migration for digital assets | $20M | Series A | Fintech | United States | Investors | |
| W WeatherPromiseCompany profile Provides weather guarantees and refunds for trips if weather is worse than promised Provides weather guarantees and refunds for trips if weather is worse than promised | $12.8M | Series A | Travel tech | United States | Investors | |
| RL Develops AI operating system for oncology workflows | $11.1M | Series A | AI | United States | Investors | |
Vivere OncotherapiesCompany profile Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells. Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells. | $10M | Series A | Biotech | United States | Investors | |
| K Provides payments platform for restaurants, bars, and clubs | €12M | Series A | Fintech | — | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Palomma, Easol, Vera Health
56rounds0led - 2Andreessen Horowitz (a16z)
Larridin, Eka Robotics, TypeSafe AI
35rounds10led - 3General Catalyst
Onodrim Industries, Hyperbolic, Baba
28rounds2led - 4Accel
Humyn Labs, Dreamteam, SE3
25rounds8led - 5Alumni Ventures
Larridin, Chariot Claims, RegCell, Inc.
24rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.